Phase 1 Chronic Myeloid Leukaemia (CML) Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Completed
Phase 1
A study to evaluate safety, tolerability and pharmacokinetics of ELVN-001 in Normal Healthy Participants- Part B
Parkinson's Disease (PD)Chronic Myeloid Leukaemia (CML)
Enliven Therapeutics, Inc.15 enrolled1 locationACTRN12624000116527
Completed
Phase 1
A study to evaluate safety, tolerability and pharmacokinetics of ELVN-001 in Normal Healthy Participants- Part A
Parkinson's Disease (PD)Chronic Myeloid Leukaemia (CML)
Enliven Therapeutics, Inc.15 enrolled1 locationACTRN12624000115538
Terminated
Phase 1
A Phase Ib study of lenalidomide in combination with imatinib for adult patients with chronic myeloid leukaemia in second molecular remission
Chronic Myeloid Leukaemia (CML)
South Australian Health & Medical Research Institute (SAHMRI)20 enrolled1 locationACTRN12615001169538